Roche Venture Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals
  • Investments
  • 157

  • Portfolio
  • 28

  • Exits
  • 92

Exits

Roche Venture Fund General Information

Description

Founded in 2002, Roche Venture Fund is the corporate venture capital arm of Roche Holding based in Basel, Switzerland. The firm prefers to make investments in early-stage life science companies operating in the pharmaceuticals and diagnostics sectors.

Contact Information

Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Primary Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland
+41 061 000 00 00

Roche Venture Fund Investments (157)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
NMD Pharma 15-Feb-2022 Later Stage VC 000.00 Drug Discovery Generating Revenue 0000000 0000000000 00.0
0000000 0000000000 19-Jan-2022 00000 00000 000.00 Drug Discovery Startup
00000000 11-Jan-2022 00000 00000 00000 Laboratory Services (Healthcare) Clinical Trials - General
0000 (0000 0000000 22-Dec-2021 00000 00000 00.000 Drug Discovery Pre-Clinical Trials 0000000 0000000000 00.0
00000000 05-Nov-2021 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue 0000000 0000000000 00.0
000000 00000000000 24-Sep-2021 0000 00000 Drug Discovery Clinical Trials - Phase 1
0000000 0000000000 17-May-2021 00000 00000 0000 Drug Discovery Stealth 00000 0000000 00.0
0000 00000000 27-Apr-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1 000000 000000000000 00
Entrada Therapeutics 31-Mar-2021 Later Stage VC 00000 Drug Delivery Pre-Clinical Trials 000000 000000000000 00
Centessa Pharmaceuticals 29-Jan-2021 Early Stage VC 00000 Drug Discovery Clinical Trials - Phase 3
You’re viewing 10 of 157 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Venture Fund Exits (92)

Company Name Exit Date Exit Type Exit Size
Entrada Therapeutics 02-Nov-2021 IPO 00000
000000 00000000000 24-Sep-2021 000000000000000000 00000
0000 00000000000 10-Aug-2021 000000000000000000
0000000 10-Jun-2021 0000000 000000 00000
00000000 000000000 28-May-2021 000 00000
0000000 0000000000 01-Apr-2021 000000000000000000 00.000
000000 00000000000 01-Apr-2021 000000000000000000 000.00
0000 00000000 01-Feb-2021 000000000 00000000
Senseonics 01-Feb-2021 Secondary Transaction - Open Market
Palladio Biosciences 01-Jan-2021 Merger/Acquisition
You’re viewing 10 of 92 exits. Get the full list »

Roche Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Roche Venture Fund Team (13)

Name Title Deals Funds Boards Office
Carole Nuechterlein JD Head of Venture Fund 00 0 00 Basel, Switzerland
David Evans Investment Director Basel, Switzerland
Nisha Marathe Ph.D Investment Director 0 0 0 South San Francisc, CA
Gabriella Zöch Project Manager Basel, Switzerland
Monique Schiersing Ph.D Senior Investment Director 00 0 0 Basel, Switzerland
You’re viewing 5 of 13 team members. Get the full list »

Roche Venture Fund Co-Investors (158)

Name With Exits Lead Partner Series Industry
5AM Ventures 7 00 Series chart Industry bar
Boxer Capital 0 0 0 Series chart Industry bar
Janus Henderson Investors 0 0 Series chart Industry bar
Logos Capital 0 0 Series chart Industry bar
Wellington Management 0 0 Series chart Industry bar
You’re viewing 5 of 158 co-investors. Get the full list »